All AbMole products are for research use only, cannot be used for human consumption.
TCN-201 is a selective GluN2A-containing N-methyl-D-aspartate receptor (NMDAR) antagonist with IC50 of 0.326 μM. TCN-201 displays selectivity for GluN1/GluN2A NMDARs over GluN1/GluN2B containing NMDARs, in assays using two-electrode voltage-clamp (TEVC) recordings of NMDAR currents from Xenopus laevis oocytes expressing either GluN1/GluN2A or GluN1/GluN2B NMDARs. Similar to TCN 213, the degree of inhibition produced by TCN-201 is dependent on the concentration of the GluN1-site co-agonist, glycine (or D-serine), and is independent of the glutamate concentration. In regard to glycine at 3 μM, 10 μM, and 30 μM, the IC50 values of TCN-201 are 0.446 μM, 0.746 μM, and 3.89 μM, respectively, while with D-serine at 3 μM, 10 μM, and 30 μM, the IC50 values of TCN-201 are 0.326 μM, 0.816 μM, and 1.92 μM, respectively. TCN-201 acts in a non-competitive manner but its equilibrium constant at GluN1/GluN2A NMDARs indicates TCN-201 is around 30-times more potent than TCN 213. TCN-201 shows only modest antagonism of NMDAR-mediated currents recorded from young (DIV 9-10) neurones, but gives a strong block in older cultures (DIV 15-18) or in cultures where GluN2A subunits have been over-expressed. TCN-201 antagonism of NMDAR-mediated currents shows a negative correlation with their ifenprodil sensitivity and therefore, in combination with ifenprodil, can be used to monitor, pharmacologically, the expression levels of GluN2A and GluN2B NMDAR subunits in neuronal populations.
| Molecular Weight | 461.89 |
| Formula | C21H17ClFN3O4S |
| CAS Number | 852918-02-6 |
| Solubility (25°C) | DMSO ≥ 150 mg/mL |
| Storage | 4°C, protect from light, dry, sealed |
| Related GluR Products |
|---|
| AZD6765
AZD6765 is an NMDA receptor antagonist. |
| LY404039
LY404039 is a potent, selective and orally active agonist of recombinant human mGlu2, mGlu3 receptors with Ki of 149 nM, 92 nM respectively. |
| Felbamate
Felbamate(Felbatol) is an anticonvulsant compound used in epilepsy research. |
| CTEP
CTEP (RO4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, shows >1000-fold selectivity over other mGlu receptors. |
| VU 0361737
VU 0361737 is a selective positive allosteric modulator (PAM) for mGlu4 receptor with EC50 of 240 nM and 110 nM at human and rat receptors, respectively. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
